1. Phosphatidate phosphohydrolase from the particle-free supernatant of rat liver was assayed by using emulsions of phosphatidate as substrate. 2. The inhibition of the phosphohydrolase by chlorpromazine was of a competitive type with respect to phosphatidate. The potency of various amphiphilic cationic drugs as inhibitors of this reaction was related to their partition coefficients into a phosphatidate emulsion. 3. The effect ofchlorpromazine on the phosphohydrolase activity was complementary rather than antagonistic towards Mg2+. Chlorpromazine stimulated the phosphohydrolase activity in the absence of added Mg2+ and was able to replace the requirement for Mg2+. However, at optimum concentrations of Mg2+, chlorpromazine inhibited the reaction, as did Ca2+. The phosphohydrolase activity was also stimulated by Co2+ and to a lesser extent by Mn2+, Fe2+, Fe3+, Ca2+, spermine and spermidine when Mg2+ was not added to the assays. 4. It is concluded that the inhibition of phosphatidate phosphohydrolase by amphiphilic cations can largely be explained by the interaction of these compounds with phosphatidate, which changes the physical properties of the lipid, making it less available for conversion into diacylglycerol. 5. The implications of these results to the effects of amphiphilic cations in redirecting glycerolipid synthesis at the level of phosphatidate are discussed.
A large variety of amphiphilic cationic drugs, which are used widely in clinical medicine, are able in vitro to inhibit phosphatidate phosphohydrolase (EC 3.1.3.4) (Brindley & Bowley, 1975) and to stimulate phosphatidate cytidylyltransferase (EC 2.7.7.41) . These events may lead to a redirection of glycerolipid metabolism away from the production of triacylglycerol, phosphatidylcholine and phosphatidylethanolamine and towards the synthesis of the acidic phospholipids (Eichberg & Hauser, 1974; Brindley & Bowley, 1975; Abdel-Latif & Smith, 1976; Bazan et al., 1976) . Such an action could contribute to the pharmacological effects of some of these drugs (Brindley & Bowley, 1975; Brindley et al., , 1976 and to some of their toxic effects (Michell et al., 1976; Brindley et al., 1977) . The ability of these cationic drugs to inhibit phosphatidate phosphohydrolase could be an important property, since this enzyme shows many of the characteristics of a regulatory enzyme (Vavrecka et al., 1969; Mangiapane et al., 1973; Lamb & Fallon, 1974; Fallon et al., 1977) .
It was previously proposed that the inhibition of phosphatidate phosphohydrolase by the cationic drugs could bc cau3ed by their physical interaction Vol. 165 with phosphatidate (Brindley & Bowley, 1975; . This could lead to the displacement of bivalent cations from the phosphatidate and to a change in the charge characteristics around this lipid (Bangham et al., 1965; Papahadjopoulos, 1970; Dawson & Hauser, 1970; Traynor & Kunze, 1975 ; Lee, 1976) . The association of the drugs with phosphatidate is one example of a general interaction with acidic phospholipids.
The present work was therefore undertaken to investigate whether the inhibition of phosphatidate phosphohydrolase could be explained by the proposed model and also to determine the relation between bivalent and amphiphilic cations. Since a large portion of the phosphatidate phosphohydrolase which is active in glycerolipid synthesis in rat liver is isolated in the particle-free supernatant , this fraction was used as a source of enzyme.
Materials and Methods
Male Wistar rats and most of the chemicals used in this investigation were obtained as described previously (Sanchez et al., 1973; Brindley & Bowley, 1975 , except that the phosphatidate was converted into its acid form by using the extraction procedure of Hajra et al. (1968) immediately before Chelex treatment.
Preparation of the particle-free supernatant from rat liver This was prepared as described by . The particle-free supernatant was dialysed against 0.3M-sucrose, adjusted to pH7.4 with KHCO3, and containing 0.5mM-dithiothreitol. In the experiments described in Fig. 4 ,2.5 mM-EDTA, adjusted to pH 7 with KOH, was added to the dialysis medium.
Determination ofprotein
Protein concentrations were determined by using a biuret method (Hiibscher et al., 1965) .
Determination ofphosphate
Total phosphate and Pi concentrations were determined by the methods of Bartlett (1959) and Ames (1966) respectively. Amphiphilic amines are known to interfere with the phosphate determination, and these were removed by chloroform extraction before the analysis for Pi (Ueda & Wada, 1970) .
Determination ofmagnesium
Samples were digested at approx. 22°C for 60h after adding 0.1 vol. of conc. HNO3. Any precipitates which were formed were removed by sedimentation in a bench centrifuge. The total Mg2+ concentration was determined by using a Unicam SP. 90 atomicabsorption spectrophotometer and a standard MgCl2 solution (BDH Chemicals, Poole, Dorset, U.K.), which was treated in the same way as the samples. It was then possible to calculate the concentration of free Mg2+ in the assays which contained EDTA by using the calculations described by Raaflaub (1966) .
Determination ofamphiphilic amines
The concentrations of amphiphilic amines in the experiments performed to measure their partition coefficients were determined by absorption spectroscopy and compared with standard solutions. Absorption measurements were performed at the following wavelengths (extinction coefficients in units of litre mol-l cm'1 in parentheses): chlorpromazine at 305nm (3900); cinchocaine at 326nm (3300); mepyramine at 307 nm (4800); trifluoperazine at 307nm (4300); desipramine at 252nm (6800); amitriptyline at 250nm (9500); N-(2-benzoyloxyethyl)norfenfluramine methanesulphonate (compound S-15 13) at 271 nm (1400).
Measurement of phosphatidate phosphohydrolase activity
The method was similar to those described previously by and Lamb & Fallon (1974 
Experimental and Results
Interaction between phosphatidate and amphiphilic cations and the inhibition of phosphatidate phosphohydrolase activity Amphiphilic cations are known to interact with phospholipids and to bind to biological membranes (Kawant & Seeman, 1969; Hauser et al., 1969; Papahadjopoulos, 1972; Fernandez & Cerbon, 1973; Bickel & Steele, 1974; Scherphof & Westenberg, 1975; Johnson et al., 1976; Wilschut et al., 1976; Seydel & Wasserman, 1976) . Hauser et al. (1969) and Carey et al. (1976) showed that this interaction was specific for acidic phospholipids (e.g. phosphatidylserine) with little interaction with zwitterionic lipids (e.g. phosphatidylcholine). Papahadjopoulos et al. (1975) Hansch & Glave (1971) . The hydrophobicity of the drugs is directly correlated with the ability to inhibit the phosphohydrolase (r = 0.96; P<0.001; Fig. 1 ).
From these results it was predicted that the inhibition of phosphatidate phosphohydrolase by the drugs should be of a competitive type with respect to phosphatidate. This prediction was tested by using chlorpromazine as an example of an amphiphilic amine (Fig. 2) . The Relationship between the potency of some amphiphilic cationic drugs in inhibiting phosphatidate phosphohydrolase and their partition coefficients into a phosphatidate emulsion The assay of phosphatidate phosphohydrolase and the measurement of the partition coefficients are described in the Materials and Methods section. The error bars show the range of the partition coefficients obtained from at least two independent experiments. ED50 refers to the concentration of drug required to produce a 50% inhibition of phosphatidate phosphohydrolase activity, and this value is accurate to within 10%. It was calculated from the results of three independent experiments as described by Dodds et al. (1976) . o, Mepyramine; OL, cinchocaine; A, compound S-1513; v, amitriptyline; *, desipramine; *, chlorpromazine; *, trifluoperazine. The results were obtained with six different preparations of phosphohydrolase and are expressed relative to the calculated maximum velocity in the individual experiments. These were calculated by Lineweaver & Burk (1934) analysis by using a weighted regression procedure (Wilkinson, 1961) Wilkinson (1961) analysis, the results are consistent with there being a common point of intersection in the range where 1/[phosphatidate] = 0.5-0.7mm-r (Fig. 2) . The results in Fig. 2 are therefore consistent with the type of competitive inhibition that involves the interaction of the inhibitor with one of the substrates of the reaction (Sluyterman & Wijdenes, 1973) , and such an interaction was demonstrated in Fig. 1 There are reports that phosphatidate phosphohydrolase activity is not stimulated by bivalent cations (Coleman & Hubscher, 1962; Smith et al., 1967; Caras & Shapiro, 1975; Kent & Vagelos, 1976) . By contrast, Mg2+ ions have been reported to stimulate phosphohydrolase activity (Sedgwick & Hubscher, 1965 Mitchell et al., 1971; Jamdar & Fallon, 1973; Call & Williams, 1973; Lamb & Fallon, 1974; Hosaka et al., 1975; . Other bivalent cations either stimulate (Sedgwick & Hubscher, 1965) or inhibit (Jamdar & Fallon, 1973; Lamb & Fallon, 1974) . There also appear to be two different phosphatidate phosphohydrolase activities in liver, heart and adipose tissue: the mitochondrial activities were not activated by Mg2+, whereas those in the microsomal and supernatant fractions were (Jamdar & Fallon, 1973; Lamb & Fallon, 1974; Kako & Patterson, 1975 the presence of 1-1.75 mM-chlorpromazine, which was used as an example of an amphiphilic cation. The molar ratio of phosphatidate/chlorpromazine in the assay system which gave this activity was approximately 1: 1.
This stimulation by chlorpromazine and its interrelationship with the concentration of Mg2+ was studied further (Fig. 3) . The maximum stimulation by chlorpromazine was achieved over a narrow range of concentrations, and at pH6.4 was greater (P<0.05 from five independent experiments) than that obtained with Mg2+. Higher concentrations of chlorpromazine caused the activity to decrease rapidly, and a similar effect was obtained with high concentrations of the bivalent inorganic ions that were investigated. As the concentration of Mg2+ was increased in the assay, the relative stimulation by chlorpromazine was decreased (P<0.05 from three independent experiments; see also Fig. 3) , and the concentration of the amine required for optimum activity was lowered. At pH7, the maximum stimulations produced by chlorpromazine and Mg2+ were not significantly different (Fig. 4a) .
The phosphatidate used in these experiments was freed of bivalent cations by the acid extraction and Chelex chromatography used in its preparation (see the Materials and Methods section). The enzyme preparation used in the assay was also dialysed overVol. 165 night. Some of the problems encountered in the past in using phosphatidate emulsions to assay the soluble phosphohydrolase may have been caused by the Ca2+ that was probably still bound to the substrate. In the present experiments, 1.8mM-CaCl2 caused a 50% inhibition of phosphohydrolase activity in the presence of 5 mM-MgCl2.
Although Fig. 3 appears to show that chlorpromazine can efficiently replace the requirement for Mg2+, it does not exclude the possibility that phosphatidate phosphohydrolase might require low concentrations (in the pM range) of Mg2+ for activity. This possibility was investigated in the experiments described in Fig. 4 . These assays were performed at pH 7.0 rather than at 6.4 to increase the chelation of Mg2+ by EDTA. The total concentration of Mg2+ in the basic assay system in three independent experiments was 9-13 fM and was derived mainly from the 
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[Chlorpromazine] (mM) Fig. 4 . Effects of chlorpromazine, Mg2+ and EDTA on the activity ofphosphatidate phosphohydrolase at pH 7 The particle-free supematant used in these experiments was dialysed against 0.3M-sucrose containing 0.5mm-dithiothreitol and 2.5mm-EDTA, adjusted to pH7 with KOH. The pH of the assay was increased from pH6.4 to 7.0 to increase the chelation of Mg2+ to the EDTA. The basic assay system contained in a volume of 0.25ml: 20mM-Tris/maleate buffer, pH7, 1 mm-dithiothreitol, 1 .5mM-potassiumphosphatidate, 0.5mg of fatty acid-poor bovine serum albumin and 0.4mg of particle-free supernatant protein. This basic assay medium also contained 0.3-0.4mM-EDTA, which was derived from the enzyme preparation. The phosphohydrolase activity was measured over 20min at 37°C (see the Materials and Methods section). (a) Effects of adding EDTA to the basic system (-) or to incubations which contained either 2mM-MgCI2 (A) or 1.2mr-chlorpromazine (U). (Fig. 4a) . When 2mM-MgCI2 was added to the basic system the concentration of 'free' Mg2+ was calculated to be 1.6-1.8 mm, and this produced an optimum stimulation of phosphohydrolase activity. The further addition of 8mM-EDTA decreased the concentration of 'free' Mg2+ to 0.6-0.7nm and the phosphohydrolase activity under these conditions was the same as if no Mg2+ had been added. By contrast, EDTA failed to inhibit completely the chlorpromazine-stimulated activity (Fig. 4 ). An optimum stimulation of phosphohydrolase activity was obtained with 1.2mM-chlorpromazine (Fig. 4b) 
Discussion
The results in the present paper are compatible with the following explanation for the inhibition of phosphatidate phosphohydrolase by amphiphilic cations. The drugs interact with the phosphatidate (Figs. 1 and 2 ) and two parts of their structure are involved. The hydrophobic region of the drug partitions into the biological or artificial membrane in which phosphatidate is present. This explains the correlation between the inhibitory potential of the drug and its partition coefficient (Fig. 1) . In addition, the positively charged amine group is attracted by electrostatic forces to the negatively charged phosof chlorpromazine in assays which contained no further addition of EDTA (0), an additional 8mM-EDTA (O) and an additional 16mmm-EDTA (A). The error bars, where shown, represent the S.D. from three independent experiments, except on the 8imM-EDTA curve, where they are the ranges from two independent experiments. 1977 phate group (Hauser et al., 1969; Cerbon, 1972; Papahadjopoulos, 1972; Giotta et al., 1974; Ragazzi et al., 1975; Carey et al., 1976; Lee, 1976 (Brindley & Bowley, 1975) . The inhibition of phosphatidate phosphohydrolase by amphiphilic amines probably results from a change in the physical properties ofthe phosphatidate. These could include the packing arrangement of the lipid in the membrane and its effective electrical potential (Bangham et al., 1965; Papahadjopoulos, 1970; Papahadjopoulos et al., 1975; Lee, 1976; Wilschut et al., 1976 (Fig. 4) . The requirement for Mg2+ could be partially replaced by Co2+ and Mn2+. However, Ca2+ was much less effective. Although Ca2+ may change the physical properties of the phosphatidate emulsion in a simlar way to Mg2+, it also seems to be an inhibitor of phosphatidate phosphohydrolase activity.
These results have implications in defining specific assay conditions for different phosphohydrolases such as the Mg2+-dependent and Mg2+-independent activities described by Jamdar & Fallon (1973) , Lamb & Fallon (1974) and Kako & Patterson (1975 Fig. 3 ; . However, the cationic drugs could not completely replace the requirement for Mg2+ in the cytidylyltransferase reaction. Interaction with relatively high concentrations of amphiphilic cations favours the formation of CDPdiacylglycerol, whereas it inhibits diacylglycerol synthesis . The inhibition by high concentrations of cationic drugs in the presence of Mg2+ is of a competitive type with respect to phosphatidate for the phosphatidate phosphohydrolase (Fig. 2) , but is of a non-competitive type in the cytidylyltransferase reaction . Since the inhibition is competitive for the phosphohydrolase reaction, the concentration of drug required to produce a 50 % inhibition ( Fig. 1 ; Brindley & Bowley, 1975) only describes the rank order ofthe potencies ofthe drugs. The phosphatidate in the cell would be expected to interact with bivalent cations such as Mg2+ and this should favour the inhibition by the drugs.
Amphiphilic amines may also interact directly with phosphatidate phosphohydrolase and thus change its activity. However, the interaction of amphiphilic cationic drugs with phosphatidate itself provides a reasonable explanation for the simultaneous inhibition of phosphatidate phosphohydrolase and the stimulation of phosphatidate cytidylyltransferase.
